FOLD insider transactions
Amicus Therapeutics Inc. (FOLD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for FOLD
- Director Wheeler Craig A returned $1,227,150 worth of shares to the company (84,631 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Mcglynn Margaret G returned $1,372,150 worth of shares to the company (94,631 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Whitman Burke W returned $1,719,671 worth of shares to the company (118,598 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Sblendorio Glenn returned $2,067,178 worth of shares to the company (142,564 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Roberts Eiry returned $1,105,988 worth of shares to the company (76,275 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Bleil Lynn Dorsey returned $1,652,144 worth of shares to the company (113,941 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Kelly Michael Aaron returned $1,050,786 worth of shares to the company (72,468 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Raab Michael returned $1,679,926 worth of shares to the company (115,857 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Accounting Officer Prout Samantha returned $1,826,290 worth of shares to the company (125,951 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Development Officer Castelli Jeff returned $6,192,790 worth of shares to the company (427,089 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Legal Officer Rosenberg Ellen returned $6,944,021 worth of shares to the company (478,898 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael returned $3,216,260 worth of shares to the company (221,811 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Financial Officer Harford Simon N.R. returned $2,082,128 worth of shares to the company (143,595 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L returned $14,625,860 worth of shares to the company (1,008,680 units at $14.50), closing all direct ownership in the company (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L sold $322,839 worth of shares (22,500 units at $14.35), decreasing direct ownership by 2% to 998,680 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 75,000 shares at a strike of $6.10 and sold $1,073,182 worth of shares (75,000 units at $14.31) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Legal Officer Rosenberg Ellen covered exercise/tax liability with 43,109 shares, decreasing direct ownership by 8% to 464,601 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Development Officer Castelli Jeff covered exercise/tax liability with 30,007 shares, decreasing direct ownership by 7% to 409,311 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Accounting Officer Prout Samantha covered exercise/tax liability with 15,683 shares, decreasing direct ownership by 11% to 125,951 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael covered exercise/tax liability with 23,879 shares, decreasing direct ownership by 10% to 221,811 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L covered exercise/tax liability with 108,602 shares, decreasing direct ownership by 10% to 1,021,180 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Financial Officer Harford Simon N.R. covered exercise/tax liability with 71,303 shares, decreasing direct ownership by 33% to 143,595 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael sold $363,380 worth of shares (25,642 units at $14.17), decreasing direct ownership by 9% to 245,690 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 70,426 shares at a strike of $9.03 and sold $846,011 worth of shares (77,926 units at $10.86), decreasing direct ownership by 0.66% to 1,129,782 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael sold $282,073 worth of shares (25,643 units at $11.00), decreasing direct ownership by 9% to 271,332 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 14,587 shares at a strike of $9.03 and sold $146,011 worth of shares (14,587 units at $10.01) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Accounting Officer Prout Samantha was granted 32,193 shares, increasing direct ownership by 29% to 141,634 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Development Officer Castelli Jeff exercised 50,000 shares at a strike of $9.03 and sold $773,659 worth of shares (76,158 units at $10.16), decreasing direct ownership by 6% to 439,318 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael sold $258,933 worth of shares (25,643 units at $10.10), decreasing direct ownership by 8% to 296,975 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 14,587 shares at a strike of $9.03 and sold $146,522 worth of shares (14,587 units at $10.04) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Legal Officer Rosenberg Ellen exercised 95,621 shares at a strike of $5.38 and sold $958,478 worth of shares (95,621 units at $10.02) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael sold $243,860 worth of shares (25,643 units at $9.51), decreasing direct ownership by 7% to 322,618 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Financial Officer Harford Simon N.R. covered exercise/tax liability with 12,529 shares, decreasing direct ownership by 6% to 214,898 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Mcglynn Margaret G was granted 20,414 shares, increasing direct ownership by 29% to 91,550 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Raab Michael was granted 20,414 shares, increasing direct ownership by 21% to 115,857 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Sblendorio Glenn was granted 20,414 shares, increasing direct ownership by 21% to 115,857 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Kelly Michael Aaron was granted 20,414 shares, increasing direct ownership by 39% to 72,468 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Roberts Eiry was granted 20,414 shares, increasing direct ownership by 37% to 76,275 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Bleil Lynn Dorsey was granted 20,414 shares, increasing direct ownership by 22% to 113,941 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Wheeler Craig A was granted 20,414 shares, increasing direct ownership by 32% to 84,631 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Director Whitman Burke W was granted 20,414 shares, increasing direct ownership by 21% to 118,598 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L covered exercise/tax liability with 13,375 shares, decreasing direct ownership by 1% to 1,137,282 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 400 shares at a strike of $9.03 and sold $4,000 worth of shares (400 units at $10.00) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Accounting Officer Prout Samantha was granted 27,416 shares and covered exercise/tax liability with 13,500 shares, increasing direct ownership by 15% to 109,441 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Development Officer Castelli Jeff was granted 52,338 shares and covered exercise/tax liability with 22,724 shares, increasing direct ownership by 7% to 465,476 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael was granted 52,338 shares and covered exercise/tax liability with 20,593 shares, increasing direct ownership by 10% to 348,261 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L was granted 137,075 shares and covered exercise/tax liability with 70,711 shares, increasing direct ownership by 6% to 1,150,657 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Legal Officer Rosenberg Ellen was granted 64,800 shares and covered exercise/tax liability with 28,584 shares, increasing direct ownership by 8% to 507,710 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Legal Officer Rosenberg Ellen covered exercise/tax liability with 25,220 shares and was granted 112,495 shares, increasing direct ownership by 23% to 471,494 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Accounting Officer Prout Samantha was granted 34,614 shares and covered exercise/tax liability with 13,015 shares, increasing direct ownership by 29% to 95,525 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief People Officer Clark David Michael covered exercise/tax liability with 20,060 shares and was granted 69,228 shares, increasing direct ownership by 18% to 316,516 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L covered exercise/tax liability with 69,489 shares and was granted 266,528 shares, increasing direct ownership by 22% to 1,083,693 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Development Officer Castelli Jeff covered exercise/tax liability with 24,416 shares and was granted 83,073 shares, increasing direct ownership by 16% to 435,862 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Financial Officer Harford Simon N.R. was granted 83,073 shares and covered exercise/tax liability with 7,482 shares, increasing direct ownership by 50% to 227,427 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 7,500 shares at a strike of $8.61 and sold $75,124 worth of shares (7,500 units at $10.02) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 7,901 shares at a strike of $12.28 and sold $98,800 worth of shares (7,901 units at $12.50) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 7,500 shares at a strike of $8.61 and sold $85,960 worth of shares (7,500 units at $11.46) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 7,500 shares at a strike of $8.61 and sold $79,492 worth of shares (7,500 units at $10.60) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- President and CEO Campbell Bradley L exercised 7,500 shares at a strike of $8.61 and sold $87,798 worth of shares (7,500 units at $11.71) (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)
- Chief Financial Officer Harford Simon N.R. covered exercise/tax liability with 12,529 shares, decreasing direct ownership by 8% to 151,836 units (SEC Form 4)4 - AMICUS THERAPEUTICS, INC. (0001178879) (Issuer)